We are live on ! Find out more
LCS

Levin Capital Strategies Portfolio holdings

AUM $1.49B
1-Year Est. Return 30.44%
This Fund
S&P 500
This Quarter Est. Return
+3.48%
1 Year Est. Return
+30.44%
3 Year Est. Return
+88.59%
5 Year Est. Return
+121.06%
10 Year Est. Return
+327.09%
AUM
$5.61B
AUM Growth
-$215M
Cap. Flow
-$399M
Cap. Flow %
-7.11%
Top 10 Hldgs %
40.7%
Holding
360
New
57
Increased
84
Reduced
99
Closed
57

Top Buys

Rank Stock Value
1
WHR icon
Whirlpool
WHR
+$117M
2
GE icon
GE Aerospace
GE
+$90.3M
3
M icon
Macy's
M
+$76.1M
4
HPE icon
Hewlett Packard
HPE
+$75.5M
5
HES
Hess
HES
+$69.2M

Top Sells

Rank Stock Value
1
TMO icon
Thermo Fisher Scientific
TMO
+$102M
2
CI icon
Cigna
CI
+$88M
3
TGT icon
Target
TGT
+$84.9M
4
KKR icon
KKR & Co
KKR
+$57.2M
5
BIO icon
Bio-Rad Laboratories Class A
BIO
+$48.8M

Sector Composition

Rank Sector Weight
1 Financials 21.97%
2 Technology 16.82%
3 Healthcare 10.88%
4 Materials 10.41%
5 Industrials 9.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JIVE
276
DELISTED
Jive Software, Inc.
JIVE
$194K ﹤0.01%
45,060
-89,166
-66% -$378K
MNDT
277
DELISTED
Mandiant, Inc. Common Stock
MNDT
$189K ﹤0.01%
+15,000
New +$179K
CEMP
278
DELISTED
Cempra, Inc.
CEMP
$185K ﹤0.01%
49,349
+17,825
+57% +$61.8K
EHI
279
Western Asset Global High Income Fund
EHI
$168M
$184K ﹤0.01%
18,206
COWN
280
DELISTED
Cowen Inc. Class A Common Stock
COWN
$181K ﹤0.01%
12,100
-1,900
-14% -$28.1K
WIA
281
Western Asset Inflation-Linked Income Fund
WIA
$182M
$167K ﹤0.01%
14,497
-25
-0.2% -$285
NRE
282
DELISTED
NorthStar Realty Europe Corp.
NRE
$138K ﹤0.01%
11,920
+901
+8% +$10.9K
WIW
283
Western Asset Inflation-Linked Opportunities & Income Fund
WIW
$498M
$124K ﹤0.01%
11,070
BAC.WS.A
284
DELISTED
Bank Of America Corporation Ws A
BAC.WS.A
$113K ﹤0.01%
10,000
-58,000
-85% -$665K
PAVM icon
285
PAVmed
PAVM
$38.6M
$112K ﹤0.01%
50
DHF
286
BNY Mellon High Yield Strategies Fund
DHF
$165M
$102K ﹤0.01%
30,000
INO icon
287
Inovio Pharmaceuticals
INO
$120M
$99K ﹤0.01%
+1,250
New +$99.6K
ADXS
288
DELISTED
Advaxis Inc
ADXS
$99K ﹤0.01%
805
METC icon
289
Ramaco Resources Class A
METC
$636M
$97K ﹤0.01%
+10,336
New +$110K
GLDD
290
DELISTED
Great Lakes Dredge & Dock
GLDD
$96K ﹤0.01%
24,000
+6,000
+33% +$27.6K
CRVP
291
DELISTED
Crystal Rock Holdings, Inc.
CRVP
$73K ﹤0.01%
87,806
+8,241
+10% +$6.6K
FGP
292
DELISTED
Ferrellgas Partners, L.P.
FGP
$71K ﹤0.01%
+11,770
New +$81.6K
WFT
293
DELISTED
Weatherford International plc
WFT
$66K ﹤0.01%
+10,000
New +$58.6K
ELECW
294
DELISTED
Electrum Special Acquisition Corporation
ELECW
$63K ﹤0.01%
141,046
PAVMW
295
DELISTED
PAVmed Inc. Warrant
PAVMW
$47K ﹤0.01%
19,414
RCM
296
DELISTED
R1 RCM Inc. Common Stock
RCM
$31K ﹤0.01%
+10,076
New +$28.8K
ADPT
297
DELISTED
Adeptus Health Inc
ADPT
$27K ﹤0.01%
+15,000
New +$84.2K
HOV icon
298
Hovnanian Enterprises
HOV
$705M
$23K ﹤0.01%
+400
New +$23.6K
GPIAW
299
DELISTED
GP Investments Acquisition Corp
GPIAW
$21K ﹤0.01%
40,598
EAGLW
300
DELISTED
Double Eagle Acquisition Corp. Warrant
EAGLW
$18K ﹤0.01%
32,057

Similar funds

Levin Capital Strategies's Q1 2017 Portfolio in Review

As of Q1 2017, Levin Capital Strategies held 360 positions worth $5.61B, down 3.7% from $5.82B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Levin Capital Strategies withdrew a net $399M in Q1 2017, closing 57 positions and reducing 99 holdings. Its most notable exit was Bio-Rad Laboratories Class A, an estimated $48.8M position sold in full.

By sector, the portfolio is most concentrated in Financials at 22% of assets, down from 23% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Levin Capital Strategies opened a new position in Whirlpool worth $113M.

  • Levin Capital Strategies's largest Q1 2017 buy was Whirlpool: 660,286 shares worth $113M.
  • Levin Capital Strategies added most to GE Aerospace in Q1 2017, an estimated $90.3M increase.
  • Levin Capital Strategies's biggest Q1 2017 reduction was Thermo Fisher Scientific, cutting an estimated $102M.
  • Levin Capital Strategies fully exited Bio-Rad Laboratories Class A in Q1 2017, selling an estimated $48.8M.
  • Levin Capital Strategies's ten largest holdings make up 41% of its $5.61B portfolio in Q1 2017.
  • Levin Capital Strategies opened 57 new positions and closed 57 in Q1 2017.
  • Levin Capital Strategies's portfolio value fell 3.7% quarter-over-quarter to $5.61B.

Based on Levin Capital Strategies's 13F filing for Q1 2017, filed 9 May 2017.